ASTRAZENECA PHARMA INDIA
|
The Current P/S Ratio of ASTRAZENECA PHARMA INDIA is 10.81.
| Share Price | ₹8,675.8 | Feb 04,2026 |
| Market Cap | ₹21,689.4 Cr | |
| Sales-TTM | ₹2,006.2 Cr | TTM-Standalone Results |
| Price/Sales | 10.81x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ASTRAZENECA PHARMA INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹21,689.4 Cr] as on Feb 04,2026
(/) Sales [ ₹2,006.2 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 10.81x ]
Thus, for ASTRAZENECA PHARMA INDIA , the investors are currently willing to pay '10.81 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ASTRAZENECA PHARMA INDIA !
The chart below summarizes the trend in P/S Ratio of ASTRAZENECA PHARMA INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of ASTRAZENECA PHARMA INDIA
PS Ratio Performance Analysis for ASTRAZENECA PHARMA INDIA
- ASTRAZENECA PHARMA INDIA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 9.62x.
- ASTRAZENECA PHARMA INDIA 's operated at median p/e ratio of 9.25x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ASTRAZENECA PHARMA INDIA 's p/e ratio peaked in Mar2025 at 12.54x.
- ASTRAZENECA PHARMA INDIA 's p/e ratio hit its five-year low in Mar2022 of 7.93x.
How does ASTRAZENECA PHARMA INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ASTRAZENECA PHARMA INDIA | 2,006.2 | 10.81 | 21,689.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.20 | 408,847.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.03 | 160,745.0 |
| CIPLA LTD | 28,351.1 | 3.78 | 107,075.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.13 | 136,346.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.98 | 103,507.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.20 | 86,263.9 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.72 | 91,069.2 |
| LUPIN LTD | 24,750.7 | 4.05 | 100,286.0 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.16 | 70,375.7 |
| ABBOTT INDIA LTD | 6,714.4 | 8.58 | 57,623.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ASTRAZENECA PHARMA INDIA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.16x |
| Max industry PS | 16.03x |
| Median industry PS | 6.20x |
| Average industry PS | 6.97x |
You may also like the below Video Courses